NIH funding will support five more years of nationwide research to improve diagnosis, treatment and long-term understanding of rare eosinophilic gastrointestinal diseases.
A global Phase III trial found that targeting FGFR3 with oral infigratinib improved growth in children with achondroplasia.
Researchers linked blood protein patterns to stomach changes in eosinophilic gastritis, offering clues for future disease ...
Expert at Cincinnati Children's discusses how new pediatric-specific stents offer less invasive, adaptable treatment options ...
More than 80 local middle and high school students connected with Cincinnati Children's researchers and health professionals ...
Kara Ayers, PhD, highlights her research focused on improving healthcare for kids with disabilities as well as all children. Hear from Associate Professor Kara Ayers, PhD, Developmental and Behavioral ...
In science, some of the most interesting discoveries begin with a result that contradicts our hypothesis. For years, researchers have known that the enzyme kallikrein 5 (KLK5) is involved in skin ...
The ADHD expert shares how unexpected opportunities, influential mentors, interdisciplinary collaboration and a passion for helping children have fueled her career. Growing up in rural Pennsylvania, ...
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, ...
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results